The FDA is also approving greater numbers of complex generic drugs, which are more difficult to replicate and traditionally lack competition. Strategic Planning Global Pharmacy By Jeff Lagasse , Associate Editor, Healthcare Finance | October 17, 2019 | 5:46 PM Topic: Government & Policy, Pharmacy, Population Health
